TBL-1203HI

N/A

Report date: 2025/01/26 16:34:10

Base Information

Drug NameTBL-1203HI
Drug Alias NameHIV therapeutic vaccine (Transgene Biotek)HIV therapeutic vaccine (Transgene Biotek)vaccine targeting HIV gp-120 specific B-cells (Transgene Biotek)TBL-1203HI
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulatorsB-lymphocyte inhibitors
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTransgene Biotek Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTransgene Biotek Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A